Aliment Pharmacol Ther

1. KATZ P
   Editorial: non-erosive reflux disease is often not GERD-time to change the definition or abandon the term?
   Aliment Pharmacol Ther. 2021;54:493-494.
   

   >> Share

   
   
2. ROGERS BD, Gyawali CP
   Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers?
   Aliment Pharmacol Ther. 2021;54:188-189.
   

   >> Share

   
   
3. FRAZZONI M, Frazzoni L, de Bortoli N, Savarino E, et al
   Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers? Authors' reply.
   Aliment Pharmacol Ther. 2021;54:190-191.
   

   >> Share

   
   
4. OUDE NIJHUIS RAB, Sweis R, Abdul-Razakq H, Schuitenmaker JM, et al
   Characterisation of patients with supine nighttime reflux: observations made with prolonged wireless oesophageal pH monitoring.
   Aliment Pharmacol Ther. 2021;54:144-152.
   

   >> Share

   
   

   
   Dig Dis Sci

5. HWANG YJ, Choi Y, Kim N, Lee HS, et al
   The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication.
   Dig Dis Sci. 2021 Aug 7. pii: 10.1007/s10620-021-07146.
   

   >> Share

   
   

   
   Helicobacter

6. GUO R, Wu S, Guan L, Xie Y, et al
   Dietary multivalent anti-Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients.
   Helicobacter. 2021 Aug 11:e12843. doi: 10.1111/hel.12843.
   

   >> Share

   
   
7. LEE JW, Kim N, Nam RH, Jang JY, et al
   Favorable outcomes of rescue second- or third-line culture-based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance.
   Helicobacter. 2021 Aug 12:e12844. doi: 10.1111/hel.12844.
   

   >> Share

   
   

   
   J Gastroenterol Hepatol

8. UENO M, Mano T, Kayahara T, Mizuno M, et al
   Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: It's time to step forward.
   J Gastroenterol Hepatol. 2021 Aug 8. doi: 10.1111/jgh.15652.
   

   >> Share

   
   

   
   Scand J Gastroenterol

9. CHA B, Bang BW, Shin JB, Ko EJ, et al
   Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area.
   Scand J Gastroenterol. 2021 Aug 8:1-6. doi: 10.1080/00365521.2021.1948606.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share